Key Dates

Related Announcements

PA-18-932 - Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional)

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice of Change is to note the inclusion of the National Heart, Lung, and Blood Institute (NHLBI) Catalog of Federal Domestic Assistance (CFDA) Number 93.840 to PA-18-932: Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional).

Current language:

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.121; 93.242; 93.273; 93.279; 93.307; 93.399; 93.866, 93.837, 93.838, 93.839, 93.849, 93.233

Revised language in bold and italics:

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.121; 93.242; 93.273; 93.279; 93.307; 93.399; 93.866, 93.837, 93.838, 93.839, 93.840, 93.233

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact(s)

Lawton S. Cooper, MD, MPH
National Heart, Lung, and Blood Institute (NHLBI)
Email: [email protected]
Telephone: 301-435-0419

Nicole Redmond, MD, PhD, MPH
National Heart, Lung, and Blood Institute (NHLBI)
Email: [email protected]
Telephone: 301-435-0379

Peer Review Contact(s)

Examine your eRA Commons account for review assignment and contact information (information appears two weeks after the submission due date).

Financial/Grants Management Contact(s)

Gayle Jones
National Heart, Lung, and Blood Institute (NHLBI)
Email: [email protected]
Telephone: 301-827-8040